Latest Articles

Publication Date
Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma - Oncology Nursing News

Abemaciclib Plus Letrozole Shows Activity in Endometrial Carcinoma Oncology Nursing News

Published: April 15, 2026, 4:59 p.m.
Verzenio Plus Letrozole Shows Durable Responses in Advanced Endometrial Cancer - Cure Today

Verzenio Plus Letrozole Shows Durable Responses in Advanced Endometrial Cancer Cure Today

Published: April 11, 2026, 9:14 p.m.
Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma - OncLive

Abemaciclib Plus Letrozole Displays Durable Activity in Advanced/Recurrent Endometrioid Endometrial Carcinoma OncLive

Published: April 11, 2026, 4:04 p.m.
Effects of Letrozole Alone or Combined with a GnRH Agonist on Inflammation, Folliculogenesis, and Estrogen Levels in a Rat Model of Peritoneal Endometriosis.

To evaluate the effects of letrozole alone and in combination with a gonadotropin-releasing hormone agonist on inflammatory cytokines, folliculogenesis, and hormonal profiles in a rat model of surgically induced peritoneal …

Published: March 13, 2026, midnight
Advanced Management of Severe Adenomyosis in IVF: A Personalized Approach With Extended GnRH Agonist and Letrozole Therapy.

The objective of this study is to evaluate the effectiveness of prolonged GnRH agonist (GnRH-a) suppression combined with letrozole and intensive luteal phase support in a patient with severe adenomyosis …

Published: March 9, 2026, midnight
Comparison of Letrozole with Elagolix for the Management of Endometriosis-Associated Pain: A Quasi-Experimental Study.

To compare the efficacy of Letrozole and Elagolix in the medical management of endometriosis-associated pain Study Design: A quasi-experimental study. Place and Duration of the Study: Department of Obstetrics and …

Published: March 6, 2026, midnight
The letrozole use in reproductive medicine: Beyond aromatase inhibition - a comprehensive review.

Letrozole and other aromatase inhibitors are increasingly recognized as first-line ovulation induction (OI) medications, offering an efficient and physiologic approach to ovarian stimulation that enhances outcomes in reproductive medicine. By …

Published: Feb. 17, 2026, midnight
Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach.

Endometriosis is a complex, estrogen-dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, …

Published: Feb. 13, 2026, midnight
Significance of Follicle-Stimulating Hormone Receptor Gene Single-Nucleotide Polymorphism rs6165/rs6166 Analysis for Infertility-Associated Ovarian Disease Susceptibility Prediction and Optimized Individualized Ovulation Induction/Ovarian Stimulation.

Follicle-stimulating hormone receptor (FSHR) is expressed on the plasma membrane of granulosa cells in the ovarian follicles. FSHR is involved in the development and maturation of Graafian follicles, along with …

Published: Jan. 10, 2026, midnight
Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer - OncLive

Nab-Sirolimus Plus Letrozole Shows Early Activity in Advanced/Recurrent Endometrioid Endometrial Cancer OncLive

Published: Dec. 22, 2025, 7:02 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!